Back

Engineering gene expression dynamics via self-amplifying RNA with drug-responsive non-structural proteins

Yousefpour, P.; Gregory, J. R.; Si, K.; Lonzaric, J.; Li, Y.; Wang, J.; Qureshi, K.; Ledbetter, A.; Melo, M. B.; Lemnios, A. A.; Dye, J.; Remba, T. K.; Yeung, R.; Rodriguez, L.; Guereca, M.; Wu, S.; Zhang, Y.; Dong, Y.; Weiss, R.; Irvine, D. J.

2025-06-08 bioengineering
10.1101/2025.06.08.658495 bioRxiv
Show abstract

The design of gene therapies with drug-regulatable expression of therapeutic payloads is of interest for diverse applications. We hypothesized that a regulated expression system based on alphavirus-derived self-amplifying RNAs (saRNAs), which encode 4 non-structural proteins (nsPs) that copy the RNA backbone to enable sustained expression, would have advantages in safety and simplicity of delivery. Here we designed saRNAs where payload expression is regulated by the FDA-approved drug trimethoprim (TMP), by fusing TMP-responsive degradation domains (DDs) to nsPs to regulate RNA self-amplification. Screening a library of nsP-DD fusions, we identified an optimal design with DDs fused to nsP2, nsP3, and the payload, achieving a high fold-change in expression level in response to TMP and low expression in the off state. In mice, this saRNA circuit enabled diverse dynamic expression patterns in response to oral TMP. Implementing this circuit for controlled expression of an HIV antigen, an escalating TMP regimen significantly enhanced germinal center responses critical for B cell affinity maturation. This drug- regulated RNA technology holds potential for vaccines, immunotherapies, and gene therapies.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 4%
26.4%
Similar papers in this journal
2
Nature Biomedical Engineering
○ 47 papers in training set
Top 0.1%
11.8%
Similar papers in this journal
3
Science Advances
● 1243 papers in training set
Top 3%
6.7%
Similar papers in this journal
4
Nature Biotechnology
○ 172 papers in training set
Top 0.8%
4.8%
Similar papers in this journal
5
Advanced Science
○ 286 papers in training set
Top 2%
4.0%
50% of probability mass above
6
Nature Nanotechnology
○ 32 papers in training set
Top 0.1%
4.0%
Similar papers in this journal
7
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 13%
4.0%
8
Science Translational Medicine
● 127 papers in training set
Top 0.7%
3.2%
9
ACS Nano
● 113 papers in training set
Top 0.7%
3.2%
10
Molecular Therapy
○ 81 papers in training set
Top 0.6%
3.1%
11
Science
● 477 papers in training set
Top 4%
2.4%
12
Cell
○ 431 papers in training set
Top 5%
2.1%
13
Nature Chemical Biology
○ 119 papers in training set
Top 1%
2.1%
14
Nucleic Acids Research
◐ 1281 papers in training set
Top 9%
1.7%
15
Neuron
○ 337 papers in training set
Top 4%
1.5%
16
eLife
● 5828 papers in training set
Top 55%
1.4%
17
Cell Reports
○ 1498 papers in training set
Top 23%
1.1%
18
Nature
○ 645 papers in training set
Top 10%
0.8%
19
Cell Research
○ 51 papers in training set
Top 1%
0.8%
20
Cell Chemical Biology
○ 94 papers in training set
Top 2%
0.8%
21
ACS Central Science
● 71 papers in training set
Top 2%
0.8%
22
Nature Methods
○ 385 papers in training set
Top 6%
0.8%
23
Protein & Cell
◐ 25 papers in training set
Top 0.6%
0.6%
24
Cell Systems
○ 201 papers in training set
Top 5%
0.6%
25
Journal of the American Chemical Society
● 217 papers in training set
Top 3%
0.6%
26
Nature Cell Biology
○ 118 papers in training set
Top 3%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.